华安国证生物医药ETF发起式联接A(012598)资产配置 |
|
报告日期 |
股票(元) |
债券(元) |
基金总资产(元) |
基金净值(元) |
股票占净值比 |
2024/3/31 |
0 |
- |
111,434,000 |
106,132,000 |
0% |
2023/12/31 |
0 |
- |
166,969,000 |
163,239,000 |
0% |
2023/9/30 |
0 |
- |
131,476,000 |
123,912,000 |
0% |
2023/8/13 |
111,269,000 |
- |
130,249,000 |
124,408,000 |
89% |
2023/6/30 |
85,937,300 |
- |
95,535,700 |
91,926,500 |
93% |
2023/3/31 |
49,375,100 |
- |
54,204,900 |
53,432,100 |
92% |
2022/12/31 |
62,048,100 |
- |
69,204,100 |
66,751,200 |
93% |
2022/9/30 |
35,523,900 |
- |
38,669,600 |
37,660,100 |
94% |
2022/6/30 |
33,797,000 |
- |
37,513,500 |
36,093,500 |
94% |
2022/3/31 |
29,155,000 |
- |
31,809,400 |
31,215,200 |
93% |
2021/12/31 |
32,232,700 |
- |
35,923,700 |
34,463,200 |
94% |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。